Table 1.
Selected observed of Minimum Inhibitory Concentration (MIC), Minimum Bactericidal Concentration (MBC) and Minimum Fungicidal Concentration (MFC) values for the synthesized cyclopentenones.[a]
|
CP |
Sa |
MRSA |
Ef |
VRE |
Ec |
Sc |
HEK 293T |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MIC [μg ⋅ mL−1] |
MBC [μg ⋅ mL−1] |
MIC [μg ⋅ mL−1] |
MBC [μg ⋅ mL−1] |
MIC [μg ⋅ mL−1] |
MBC [μg ⋅ mL−1] |
MIC [μg ⋅ mL−1] |
MBC [μg ⋅ mL−1] |
MIC [μg ⋅ mL−1] |
MBC [μg ⋅ mL−1] |
MIC [μg ⋅ mL−1] |
MFC [μg ⋅ mL−1] |
[% viability at 20 μM] |
|
6 |
7.81 |
>31.2 |
15.6 |
250 |
1.95 |
>15.6 |
7.81 |
>62.5 |
62.5 |
125 |
62.5 |
125 |
90 |
|
7 |
7.81 |
>62.5 |
3.91 |
>31.2 |
1.95 |
>15.6 |
3.91 |
>31.2 |
62.5 |
250 |
31.2 |
62.5 |
95 |
|
8 |
3.91 |
>31.2 |
3.91 |
>31.2 |
0.49 |
>3.91 |
0.98 |
15.6 |
62.5 |
250 |
62.5 |
125 |
65 |
|
9 |
7.81 |
250 |
62.5 |
250 |
15.6 |
500 |
nt |
nt |
nt |
nt |
31.2 |
125 |
59 |
|
20 |
7.81 |
>62.5 |
0.976 |
>7.81 |
0.976 |
>7.81 |
3.91 |
62.5 |
62.5 |
125 |
15.6 |
62.5 |
100 |
|
Vanco |
1.95 |
500 |
3.91 |
nt |
<0.49 |
>500 |
62.5 |
>500 |
|
|
|
|
|
|
NOR |
|
|
|
|
|
|
|
|
<0.49 |
500 |
|
|
|
|
NYS |
|
|
|
|
|
|
|
|
|
|
15.6 |
500 |
|
[a] The MIC corresponding to the lowest concentration at which no visible growth was observed, was assessed by the microdilution method. For MBC evaluation, the bacterial suspension on the wells was homogenized, serial‐diluted, triplicate spread on appropriate medium and incubated at 37 °C for 24 h. Data represent the median values of at least three replicates. Vanco: vancomycin. NOR: norfloxacin. NYS: nystatin. Sa: Staphylococcus aureus. MRSA: methicillin‐resistant Staphylococcus aureus. Ef: Enterococcus faecalis. VRE: vancomycin‐resistant Enterococcus faecalis. Ec: Escherichia coli. Sc: Saccharomyces cerevisiae. HEK: Human Embryonic Kidney.